OBJECTIVE: RNA interference mediated by transcription of short hairpin RNAs (shRNAs) from lentiviral expression vectors has emerged as an efficient method to effectively and specifically silence gene expression in a vast variety of mammalian cells. shRNA expression is routinely driven by a RNA polymerase III promoter, most often by the U6 promoter. Here we demonstrate that U6 promoter activity-and consequently gene silencing success-differs significantly among species. MATERIALS AND METHODS: We have modified pLeGO-G, an HIV-based third-generation lentivector, to express a 19nt shRNA sequence against the human transcription factor nuclear factor erythroid 2 or against its murine homologue, as well as an shRNA against murine JAK2, from either the human or the murine U6 promoter. Gene silencing efficiency was analyzed in a human erythroleukemic cell line, in primary human CD34(+) cells, as well as in a murine erythroleukemic cell line and in primary murine bone marrow. RESULTS: ShRNA expression from the human U6 promoter resulted in a fourfold increase in knockdown efficiency compared to expression from the murine U6 promoter in both human and murine cells. CONCLUSIONS: The U6 promoter constitutes an important determinant for efficient gene silencing by shRNAs.
OBJECTIVE: RNA interference mediated by transcription of short hairpin RNAs (shRNAs) from lentiviral expression vectors has emerged as an efficient method to effectively and specifically silence gene expression in a vast variety of mammalian cells. shRNA expression is routinely driven by a RNA polymerase III promoter, most often by the U6 promoter. Here we demonstrate that U6 promoter activity-and consequently gene silencing success-differs significantly among species. MATERIALS AND METHODS: We have modified pLeGO-G, an HIV-based third-generation lentivector, to express a 19nt shRNA sequence against the human transcription factor nuclear factor erythroid 2 or against its murine homologue, as well as an shRNA against murineJAK2, from either the human or the murine U6 promoter. Gene silencing efficiency was analyzed in a human erythroleukemic cell line, in primary humanCD34(+) cells, as well as in a murine erythroleukemic cell line and in primary murine bone marrow. RESULTS: ShRNA expression from the human U6 promoter resulted in a fourfold increase in knockdown efficiency compared to expression from the murine U6 promoter in both human and murine cells. CONCLUSIONS: The U6 promoter constitutes an important determinant for efficient gene silencing by shRNAs.
Authors: Raphaël Duvoisin; Mary A Ayuk; Gabriel Rinaldi; Sutas Suttiprapa; Victoria H Mann; Clarence M Lee; Nicola Harris; Paul J Brindley Journal: Transgenic Res Date: 2011-09-28 Impact factor: 2.788
Authors: Thomas A A Prowse; Phillip Cassey; Joshua V Ross; Chandran Pfitzner; Talia A Wittmann; Paul Thomas Journal: Proc Biol Sci Date: 2017-08-16 Impact factor: 5.349
Authors: S Koschmieder; T I Mughal; H C Hasselbalch; G Barosi; P Valent; J-J Kiladjian; G Jeryczynski; H Gisslinger; J S Jutzi; H L Pahl; R Hehlmann; A Maria Vannucchi; F Cervantes; R T Silver; T Barbui Journal: Leukemia Date: 2016-02-08 Impact factor: 11.528
Authors: Jonas Samuel Jutzi; Titiksha Basu; Maximilian Pellmann; Sandra Kaiser; Doris Steinemann; Mathijs A Sanders; Adil S A Hinai; Annelieke Zeilemaker; Sarolta Bojtine Kovacs; Christoph Koellerer; Jenny Ostendorp; Konrad Aumann; Wei Wang; Emmanuel Raffoux; Bruno Cassinat; Lars Bullinger; Brigitte Schlegelberger; Peter J M Valk; Heike Luise Pahl Journal: Blood Date: 2019-02-12 Impact factor: 22.113
Authors: Julius Wehrle; Thalia S Seeger; Sven Schwemmers; Dietmar Pfeifer; Alla Bulashevska; Heike L Pahl Journal: Haematologica Date: 2013-02-26 Impact factor: 9.941
Authors: Konrad Aumann; Anna-Verena Frey; Annette M May; Dieter Hauschke; Clemens Kreutz; Jan P Marx; Jens Timmer; Martin Werner; Heike L Pahl Journal: Blood Date: 2013-05-13 Impact factor: 22.113